Mouse models that carry mutations causing thalassemia represent a suitable tool to test in vivo new mutation-specific therapeutic approaches. Transgenic mice carrying the -globin IVSI-6 mutation (the most frequent in Middle-Eastern regions and recurrent in Italy and Greece) are, at present, not available. We report the production and characterization of a transgenic mouse line (TG- -IVSI-6) carrying the IVSI-6 thalassemia point mutation within the human -globin gene. In the TG--IVSI-6 mouse (a) the transgenic integration region is located in mouse chromosome 7; (b) the expression of the transgene is tissue specific; (c) as expected, normally spliced human -globin mRNA is produced, giving rise to -globin production and formation of a humanmouse tetrameric chimeric hemoglobin mu-globin2/ hu-globin2 and, more importantly, (d) the aberrant -globin-IVSI-6 RNAs are present in blood cells. The TG--IVSI-6 mouse reproduces the molecular features of IVSI-6 -thalassemia and might be used as an in vivo model to characterize the effects of antisense oligodeoxynucleotides targeting the cryptic sites responsible for the generation of aberrantly spliced -globin RNA sequences, caused by the IVSI-6 mutation. These experiments are expected to be crucial for the development of a personalized therapy for -thalassemia.

Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation

BREVEGLIERI, Giulia
Primo
;
MANCINI, Irene;BIANCHI, Nicoletta;LAMPRONTI, Ilaria;SALVATORI, Francesca;FABBRI, Enrica;ZUCCATO, Cristina;COSENZA, Lucia Carmela;MONTAGNER, Giulia;BORGATTI, Monica;CARANDINA, Gianni;RUBINI, Michele;AIELLO, Vincenzo;GAMBARI, Roberto
Penultimo
;
FINOTTI, Alessia
Ultimo
2015

Abstract

Mouse models that carry mutations causing thalassemia represent a suitable tool to test in vivo new mutation-specific therapeutic approaches. Transgenic mice carrying the -globin IVSI-6 mutation (the most frequent in Middle-Eastern regions and recurrent in Italy and Greece) are, at present, not available. We report the production and characterization of a transgenic mouse line (TG- -IVSI-6) carrying the IVSI-6 thalassemia point mutation within the human -globin gene. In the TG--IVSI-6 mouse (a) the transgenic integration region is located in mouse chromosome 7; (b) the expression of the transgene is tissue specific; (c) as expected, normally spliced human -globin mRNA is produced, giving rise to -globin production and formation of a humanmouse tetrameric chimeric hemoglobin mu-globin2/ hu-globin2 and, more importantly, (d) the aberrant -globin-IVSI-6 RNAs are present in blood cells. The TG--IVSI-6 mouse reproduces the molecular features of IVSI-6 -thalassemia and might be used as an in vivo model to characterize the effects of antisense oligodeoxynucleotides targeting the cryptic sites responsible for the generation of aberrantly spliced -globin RNA sequences, caused by the IVSI-6 mutation. These experiments are expected to be crucial for the development of a personalized therapy for -thalassemia.
2015
Breveglieri, Giulia; Mancini, Irene; Bianchi, Nicoletta; Lampronti, Ilaria; Salvatori, Francesca; Fabbri, Enrica; Zuccato, Cristina; Cosenza, Lucia Ca...espandi
File in questo prodotto:
File Dimensione Formato  
Brevegieri G. BioMed Research International 2015.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Full text (versione editoriale)
Licenza: Creative commons
Dimensione 3.72 MB
Formato Adobe PDF
3.72 MB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2336513
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 4
social impact